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ABSTRACT 
Many techniques are used for investigating the properties of the solid 
compounds, for example, powder X-ray diffraction (PXRD), thermal analysis, 
vibrational spectroscopy, and nuclear magnetic resonance (NMR) spectroscopy. Among 
these techniques, terahertz (THz) spectroscopy has recently gained more interest in the 
study of pharmaceutical materials. The femtosecond laser innovation enables to 
measure a new THz frequency range. Terahertz radiation lies in the frequency gap 
between the IR and microwave regions. One of the attractive properties of THz 
radiation is its ability to pass through a wide variety of materials, thus allowing the 
non-destructive inspection. Terahertz radiation can probe low-frequency crystal lattice 
vibration and weak intermolecular interactions such as hydrogen bonding and van der 
Waals force. Several studies have reported that THz spectroscopy can be used for 
monitoring solid-state dynamic processes (e.g. the dehydration process), differentiating 
and quantifying the different forms of active pharmaceutical ingredients. In my study, I 
emphasized on investigating the feasibility of THz spectroscopy as a characterizing tool 
for solid compounds. 
In Part I, the purpose of the study is to examine the potential use of THz 
spectroscopy for evaluating the formation of cocrystal. Seven known cocrystals were 
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prepared by cogrinding method and characterized by PXRD and THz spectroscopy. 
PXRD patterns of the prepared cocrystals were consisted with those of the reported 
cocrystals; this confirmed the formation of cocrystals. Terahertz spectra of cocrystals 
were different from those of the components, reflecting the changes in vibrational mode 
of molecule induced by cocrystal formation. The spectral changes observed are 
classified into 2 groups: new peak appeared and peak disappeared groups.  
In Part II, the purposes of the study are to prepare a novel complex and to 
investigate the feasibility of THz spectroscopy as a new evaluation method for complex 
formation. Ofloxacin (OFC) was used because of its poor solubility in water and 
photoinstability. I prepared a new complex of OFC with oxalic acid (OXA) by means of 
cogrinding. The obtained complex was characterized by PXRD, FT-IR spectroscopy, 
solid-state 13C NMR spectroscopy and THz spectroscopy. The results of PXRD 
indicated that OFC-OXA complex induced by cogrinding formed presumably at a molar 
ratio of 1:2. Molecular interaction between OFC and OXA was examined by FT-IR 
spectroscopy. No spectral changes in functional groups of OFC and OXA were 
observed by the complex formation, suggesting that the interaction modes of carboxylic 
and ketonic group with the surrounding functional groups might be similar before and 
after grinding. The spectral changes were different from those of other cocrystals 
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wherein hydrogen bond formation was clearly observed by FT-IR spectroscopy. 
Solid-state NMR spectroscopy was used to confirm the interaction between OFC and 
OXA. Chemical shifts found by NMR measurement suggested that the tricyclic 
aromatic portion and/or methyl group of OFC interacted with the hydroxyl group closed 
to carbon of OXA. IR and NMR results did not confirm the presence of hydrogen 
bonding among the functional groups of OFC and OXA. This complex appeared to be 
formed by weak interaction such as van der Waals and OH-πinteraction. From THz 
spectroscopy measurement, the THz spectrum of complex exhibited a distinctive 
absorption peak as compared to those of the starting materials. The change observed in 
the THz spectrum of the complex reflected the weak interaction in the OFC-OXA 
complex. It is worth noting that THz spectroscopy can probe the weak interactions 
comparing to FT-IR spectroscopy. In addition to OXA, the complex formation of OFC 
with other dicarboxylic acids such as maleic acid, glutaric acid and malonic acid was 
investigated as well. PXRD results suggested that a complex was formed between OFC 
and dicarboxylic acid at molar ratio of 1:2. Terahertz spectra of all these complexes 
showed distinct spectra from those of their components, indicating the difference in 
molecular packing. It can be assumed that THz spectroscopy is an alternative tool to 
evaluate complex formation. 
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INTRODUCTION 
It has been reported that more than 40% of active pharmaceutical ingredients 
(APIs) are poorly water soluble1. These APIs may potentially show slow dissolution, 
improper bioavailability, and insufficient therapeutic efficacy, especially when APIs 
were delivered via oral administration2. Therefore, modification of APIs to improve the 
solubility, dissolution rate and subsequent bioavailability is needed. 
 Crystal engineering has recently been investigated as a means of tailoring the 
physicochemical properties of APIs. It offers many methods to improve the 
physicochemical properties of APIs, such as complexation and cocrystal formation. The 
formation of crystalline molecular complexes involves the incorporation of an API with 
another pharmaceutically acceptable molecule in the crystal lattice. Consequently, this 
multicomponent crystal will gain a distinct physicochemical profile, which has the 
potential to improve the properties of API, such as solubility, dissolution rate, and even 
physical stability2, 3. There are many methods to make the complex e.g. evaporation and 
coprecipitation. Cogrinding, in which two substances or more are mixed and ground 
together, is an alternative method to prepare the complex easily without using organic 
solvents 4-6. 
 5 
In addition to the modification of APIs, analyzing different solid forms of APIs 
has become an essential part of drug development7. Many techniques are used for 
investigating the solid-state properties of the solid samples, for example, powder X-ray 
diffraction (PXRD), thermal analysis, vibrational spectroscopy, and nuclear magnetic 
resonance (NMR) spectroscopy. Among the vibrational spectroscopies, Raman and IR 
spectroscopy mainly probe the intramolecular vibration of molecules. On the other hand, 
PXRD, terahertz (THz) spectroscopy, and various thermal techniques predominantly 
examine the intermolecular vibration (i.e., at the lattice level),7-10. Recently, THz 
spectroscopy has gained more interest in the study of pharmaceutical materials11-13. 
 
 
 
 
 
Fig.1. Terahertz spectral region. 
 Terahertz spectroscopy covers the electromagnetic spectral range from 3 cm–1 
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various materials such as clothing, paper, cardboard, wood, leather, plastic, and ceramic. 
This property allows the non-destructive inspection of such items as mail envelopes at 
post offices and luggages at airports15. Moreover, a THz wave has low energy and thus 
can be used to detect biological samples16. Terahertz radiation can probe low-frequency 
crystal lattice vibration and weak intermolecular interactions such as hydrogen bonding 
and van der Waals force15.  
 For application, several studies have reported that THz spectroscopy can be 
used for differentiating and quantifying the different forms of APIs10, 12, 17-20 . Terahertz 
spectroscopy has also been applied to monitor solid-state dynamic processes such as 
phase transformation and dehydration process21, 22. Although many applications of THz 
spectroscopy for single component system have been reported, its use for 
multicomponent system stills a few. For example, there is a report that examining the 
cocrystal formation of phenazine and mesaconic acid23. Further investigation for general 
utility of THz spectroscopy as an evaluation method for cocrystal formation is needed. 
Hence, one part of this study was undertaken to determine the feasibility of using THz 
spectroscopy as a characterization method for formation of cocrystals.  
The purpose of another part is to prepare a novel complex of ofloxacin (OFC) 
having better physicochemical properties by complex formation. Ofloxacin is a 
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fluoroquinolone antibiotic drug, which has a broad spectrum of antibacterial activity 
and good pharmacokinetic properties. It is practically insoluble in water and is 
photochemically unstable24, 25. The effect of OFC and β-cyclodextrin complexation on 
the solubility in water and photostability of the drug has been investigated24. However, 
only a few studies have been reported about improving the solubility and dissolution 
rate of OFC. This study also aimed to investigate the feasibility of using THz 
spectroscopy as an evaluation method for complex formation. 
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EXPERIMENTAL 
Part I Characterization of cocrystals by terahertz spectroscopy 
Materials  
Piracetam (PRC) and polyethylene (ultra-high molecular weight, 
surface-modified particles, size: 53–75 µm) were obtained from Sigma-Aldrich, Inc. 
(U.S.A.). Carbamazepine (CBZ), saccharin (SAC), p-hydroxybenzoic acid (HBA), 
gentisic acid (GTS), anhydrous oxalic acid (OXA), malonic acid (MLO), and maleic 
acid (MLE) were purchased from Wako Pure Chemical Industries, Ltd. (Japan). 
Theophylline (TP) and glutaric acid (GLU) were supplied by Nacalai Tesque, Inc. 
(Japan). All chemicals were of analytical grade and used as received. 
Preparation of cocrystals 
 Cocrystals studied in this work are as follows: 
1. PRC/GTS cocrystal at a molar ratio of 1:1  
2. PRC/HBA cocrystal at a molar ratio of 1:1 
3. CBZ/SAC cocrystal at a molar ratio of 1:1 
4. TP/OXA cocrystal at a molar ratio of 2:1 
5. TP/MLO cocrystal at a molar ratio of 1:1 
6. TP/MLE cocrystal at a molar ratio of 1:1 
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7. TP/GLU cocrystal at a molar ratio of 1:1 
All cocrystals were prepared by cogrinding. Firstly, the physical mixtures 
(PMs) were prepared at a specified molar ratio in a glass vial by using a vortex mixer. 
The PMs were ground by a vibrational rod mill (CMT T1-200, CMT Co., Ltd., Japan) 
for 30 min (except for PRC/GTS system 60 min) to obtain the ground mixtures (GMs).  
Powder X-ray diffraction (PXRD) measurement 
Powder X-ray diffraction (PXRD) measurement was conducted by using a 
Rigaku Miniflex II diffractometer with CuKα radiation (Rigaku Corporation, Japan) at 
an ambient temperature. Measurements were performed at a voltage of 30 kV, a current 
of 15 mA, a scanning speed of 4 °/min over a 2θ range of 5–40°. 
Terahertz time- domain spectroscopy (THz-TDS) 
Terahertz time-domain spectroscopy (THz-TDS) measurement was performed 
by a Rayfact SpecTera (Tochigi Nikon Corporation, Japan) with the transmission 
method. Tablets, with a diameter of 13 mm and a thickness of 1 mm, were prepared by 
mixing 10 mg of sample with 90 mg of polyethylene and manual pressing in a mould. 
Polyethylene is featureless and relatively transparent in the range below 100 cm–1 and is 
a good diluent for measuring the spectra of APIs26. The measurement covered the range 
of 0.1–2 THz with a resolution of 0.098 THz (3.255 cm–1). 
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Part II Preparation of novel ofloxacin-dicarboxylic acid complex  
and characterization by terahertz spectroscopy 
Materials  
Ofloxacin (OFC), anhydrous oxalic acid (OXA), maleic acid (MLE), and 
malonic acid (MLO) were purchased from Wako Pure Chemical Industries, Ltd. (Japan). 
Glutaric acid was obtained from Nacalai Tesque, Inc. (Japan). Polyethylene (ultra-high 
molecular weight, surface-modified particles, size: 53–75 µm) was obtained from 
Sigma-Aldrich, Inc. (U.S.A.). All chemicals were of analytical grade and used without 
further purification. 
Preparation of ofloxacin-oxalic acid physical mixtures (PMs) and ground mixtures 
(GMs) 
Ofloxacin-oxalic acid PMs were prepared at various molar ratios in a glass vial 
by using a vortex mixer. The PMs were ground by a vibrational rod mill (CMT T1-200, 
CMT Co., Ltd., Japan) for 30 min to obtain the GMs.  
Powder X-ray diffraction (PXRD) measurement 
X-ray diffractograms were obtained by using a Rigaku Miniflex II 
diffractometer with CuKα radiation (Rigaku Corporation, Japan) at an ambient 
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temperature. The following conditions were used: a voltage of 30 kV, a current of 15 
mA, a scanning speed of 4 °/min over a 2θ range of 5–40°. 
Fourier transform infrared (FT-IR) spectroscopy 
Fourier transform infrared spectroscopy measurements were performed by the 
attenuated total reflectance (ATR) method. The IR spectra of the pure components, PMs, 
and GMs were recorded using a FT-IR 230 spectrophotometer (JASCO Corporation, 
Japan) in the range of 650–4000 cm–1. All spectra were recorded under the conditions: 
number of scan, 32; resolution, 4.0 cm–1. 
Solid-state nuclear magnetic resonance (NMR) spectroscopy 
 All 13C solid-state NMR spectra were recorded by using a JNM-ECA 600 
NMR spectrometer, which had a magnetic field of 14.09 T (JEOL, Japan) and operated 
at 150 MHz for 13C. Powder samples (ca. 100 mg) were filled into 4 mm silicon nitride 
(Si3N4) rotors. All spectra were acquired using variable amplitude cross-polarization 
(CP) together with magic angle spinning (MAS) at 15 kHz and a high power two-pulse 
phase-modulation 1H decoupling. The total scan for each sample (2,000–3,600) 
depended on the signal-to-noise ratio required. Pertinent acquisition parameters 
included a CP contact time of 5 ms, a 1H 90° pulse of 2.7 µs, and relaxation delays of 
2–15 s. For each experiment, 2,048 data points were acquired and zero-filled to 8,192 
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points. All spectra were externally referenced to tetramethylsilane by setting the 
methine peak of hexamethylbenzene to 17.3 ppm. 
Terahertz time- domain spectroscopy (THz-TDS) 
The THz spectra of the samples were acquired by using a Rayfact SpecTera 
(Tochigi Nikon Corporation, Japan) with the transmission method. Ten milligram of 
sample and 90 mg of polyethylene were thoroughly mixed and then manually pressed in 
a mould to form a measuring tablet with a diameter of 13 mm and a thickness of 
approximately 1 mm. Measurement were performed over the range of 0.1–2 THz with a 
resolution of 0.098 THz (3.255 cm–1). 
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Principle of terahertz time-domain spectroscopy (THz-TDS) 
Terahertz measurements have been challenging due to the difficulty associated 
with generating and detecting the THz radiation. In addition, ambient conditions create 
considerable noise in the THz region. However, recent femtosecond laser innovation 
enables to measure a new THz frequency range. The development of commercial 
instruments that utilize THz pulses has opened up the area of study to the wider 
scientific area, particularly the pharmaceutical field. Techniques using pulsed THz 
radiation are THz time-domain spectroscopy (THz-TDS) and THz imaging8, 11, 12.  
Figure 2 presents the THz-TDS equipment used throughout this study. It can be 
operated without purging dry nitrogen; this makes it easy and convenient to measure. 
Terahertz spectra were measured by transmission method. The typical setup of 
transmission THz-TDS is shown in Fig. 3. The femtosecond laser light is emitted and 
separated by a beam splitter into two beams: pump light and probe light. Pump light 
passes through the THz emitter to generate the THz light whereas probe light is focused 
onto the detector. When the THz light goes through the sample, the light is distorted by 
selective absorption of the sample, causing the delay in its arrival time at the detector. 
This transmitted beam is then focused onto a detector and detected as a time-domain 
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waveform. The data are processed by fast Fourier transform analysis in order to convert 
the delay time into the frequency of the THz signal that arrives at the detector8, 12.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 15 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Rayfact Spectera (Tochigi Nikon Corporation, Japan) – THz-TDS equipment. 
(Image from www.tochigi-nikon.co.jp) 
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Fig. 3. Schematic setup of transmission THz-TDS. 
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RESULTS AND DISCUSSION 
Part I Characterization of cocrystals by terahertz spectroscopy 
 Cocrystal is defined as a crystalline material that two or more components that 
are solid at ambient condition held together by hydrogen bonding27, 28. The main 
difference between cocrystal and salt is that in salt a proton is transferred from the 
acidic to the basic functionality of the constituent free base molecule, or vice versa if 
applicable28, 29. Cocrystal has been increasingly recognized as an attractive alternative 
for solid forms of drug products29, 30. Generally, methods used for characterization of 
cocrystal are X-ray diffraction (single crystal and powder), FT-IR spectroscopy and 
thermal analysis. In order to investigate the potential use of THz spectroscopy to 
monitor the cocrystal formation, seven kinds of cocrystals, the structure of which has 
been reported3, 31, 32, were prepared by cogrinding method. PXRD patterns of prepared 
cocrystals (Figs. 4-10) agreed with those of the reported cocrystals, confirmed that 
cocrystals were formed.  
 Figure 11 shows THz spectra of PRC/GTS system. Terahertz spectrum of PRC 
has no characteristic peak in the observed range, whereas that of GTS had absorption 
peaks at 0.88 and 1.85 THz. The cocrystal exhibited a distinctive absorption peak at 
0.68, 1.27, and 1.76 THz. Terahertz spectra of PRC/HBA system are shown in Fig. 12. 
 18 
Absorption peak of HBA was found at 1.17 THz, while broad peak was observed at 
1.47 THz in the cocrystal. For the CBZ/SAC system (Fig. 13), no peak was observed in 
THz spectrum of SAC, while CBZ had absorption peaks at 1.27 and 1.85 THz. After 
forming cocrystal, new peaks were found in 1.07 and 1.66 THz. The changes found in 
PRC/GTS, PRC/HBA and CBZ/SAC cocrystals indicated that vibration modes changed 
due to the cocrystal formation. Figures 14-17 show the THz spectra of TP/OXA, 
TP/MLO, TP/MLE and TP/GLU systems, respectively. Theophylline showed 
characteristic peaks at 0.98 and 1.66 THz, while all of dicarboxylic acids used had no 
absorption peaks in the observed frequency range. Absorption peaks of TP disappeared 
in the cocrystals (defined in the figures as GMs). These results suggested that 
vibrational mode of TP was changed by forming cocrystal. 
The spectral changes found in this study can be classified in two groups. One is 
PRC/GTS, PRC/HBA, and CBZ/SAC cocrystals where new peak appeared. Another is 
TP/OXA, TP/MLO, TP/MLE, and TP/GLU cocrystals where peak disappeared. 
Terahertz spectra of drugs were changed by cocrystal formation, reflecting the 
differences in molecular packing and vibrational modes from those of the components. 
As THz radiation probes weak interaction such as hydrogen bonding and van der Waals 
 19 
force, it is intrinsically sensitive to changes in crystalline structure9, 15. Hence, THz 
spectroscopy could be a convenient analytical method to detect the cocrystal formation. 
 20 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Powder X-ray diffraction patterns of PRC-GTS system: (a) PRC, (b) GTS,    
(c) 1:1 PM, and (d) 1:1 GM 60 min ( □ PRC,  GTS, ☆ new peak). 
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Fig. 5. Powder X-ray diffraction patterns of PRC-HBA system: (a) PRC, (b) HBA, 
(c) 1:1 PM, and (d) 1:1 GM 30 min ( □ PRC,  HBA, ☆ new peak). 
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Fig. 6. Powder X-ray diffraction patterns of CBZ-SAC system: (a) CBZ, (b) SAC, 
(c) 1:1 PM, and (d) 1:1 GM 30 min ( ○ CBZ, □ SAC, ☆ new peak). 
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Fig. 7. Powder X-ray diffraction patterns of TP-OXA system: (a) TP, (b) OXA, 
(c) 2:1 PM, and (d) 2:1 GM 30 min ( □ TP,  OXA, ☆ new peak). 
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Fig. 8. Powder X-ray diffraction patterns of TP-MLO system: (a) TP, (b) MLO, 
(c) 1:1 PM, and (d) 1:1 GM 30 min ( □ TP, ◊ MLO, ☆ new peak). 
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Fig. 9. Powder X-ray diffraction patterns of TP-MLE system: (a) TP, (b) MLE, 
(c) 1:1 PM, and (d) 1:1 GM 30 min ( □ TP, ○ MLE, ☆ new peak). 
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Fig. 10. Powder X-ray diffraction patterns of TP-GLU system: (a) TP, (b) GLU, 
(c) 1:1 PM, and (d) 1:1 GM 30 min ( □ TP,  GLU, ☆ new peak). 
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Fig. 11. Terahertz spectra of PRC-GTS system: (●) PRC, (▲) GTS, and (○) PRC-GTS 
cocrystal. 
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Fig. 12. Terahertz spectra of PRC-HBA system: (●) PRC, (∆) HBA, and (☐) PRC-HBA 
cocrystal. 
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Fig. 13. Terahertz spectra of CBZ-SAC system: (▲) CBZ, (■) SAC, and (○) CBZ-SAC 
cocrystal. 
 
 
 
 
0
2
4
6
8
10
12
0 0.5 1 1.5 2
A
bs
o
rp
tio
n
 
co
ef
fic
ie
n
t 
Frequency (THz) 
A
bs
o
rp
tio
n
 
co
ef
fic
ie
n
t 
 30 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14. Terahertz spectra of TP-OXA system. 
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Fig. 15. Terahertz spectra of TP-MLO system. 
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Fig. 16. Terahertz spectra of TP-MLE system. 
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Fig. 17. Terahertz spectra of TP-GLU system. 
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Part II Preparation of novel ofloxacin-dicarboxylic acid complex  
and characterization by terahertz spectroscopy 
Figure 18 shows PXRD patterns of the OFC-OXA system. When OFC was 
coground with OXA at a molar ratio of 1:1 for 30 min, a halo pattern was mainly 
observed with the remaining peaks of crystalline OFC (Fig. 18c). The PXRD pattern of 
the GM became halo after cogrinding for 60 min (Fig. 18d), indicating that a prolonged 
grinding time could induce the disorder of solid into the amorphous phase but could not 
facilitate complex formation. On grinding each component individually for 60 min, the 
PXRD peaks were still observed (data not shown). These results suggested that the 
OFC:OXA ratio of 1:1 might not be a suitable stoichiometry for the complex. When the 
molar ratio of OFC: OXA was changed to 1:2, new PXRD peaks were found for the 
GM (Fig. 18f). The PXRD pattern of the PM at a molar ratio of 1:2 (Fig. 18e) was the 
superimposition of the diffraction peaks of intact OFC and OXA (Fig. 18a and 18b). 
The PXRD pattern of the GM differed from those of the constituents; this confirmed the 
formation of a new complex phase. For the GM with a molar ratio of 1:3, new 
diffraction peaks were observed in addition to those corresponding to the excess amount 
of OXA (Fig. 18g). These results indicated that the OFC-OXA complex formed 
presumably at a molar ratio of 1:2 by cogrinding. 
 35 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18. Powder X-ray diffraction patterns of the OFC–OXA system: (a) OFC, (b) OXA, 
(c) 1:1 GM 30 min, (d) 1:1 GM 60 min, (e) 1:2 PM, (f) 1:2 GM 30 min, and (g) 1:3 GM 
30 min (○ OFC, □ OXA, ☆ new peak). 
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The physicochemical properties of OFC, OXA, PM, and GM at a molar ratio of 
1:2 were investigated by other solid-state analytical methods. Molecular interaction 
between OFC and OXA was examined by FT-IR spectroscopy. All the spectra of the 
OFC-OXA system are depicted in Fig. 19. The spectrum of OXA showed a peak 
corresponding to the carbonyl (C=O) stretching of carboxylic acid at 1683 cm–1. In the 
spectrum of OFC, the bands observed at 1710 and 1621 cm–1 were assigned to the C=O 
stretching of carboxylic group and the stretching of the ketonic group, respectively 33-35. 
These bands were also observed in the IR spectra of the PM and GM (1708 and 1620 
cm–1 for PM; 1709 and 1624 cm–1 for GM), suggesting that the interaction modes of 
carboxylic and ketonic groups with the surrounding functional groups might be similar 
before and after grinding.  This system is different from other typical complex 
formation systems wherein hydrogen bond formation is clearly observed by FT-IR 
spectroscopy5, 36 . 
However, some changes were found in the vibrational range of aromatic rings 
of OFC. The bands at 1548 and 1521 cm–1 corresponding to the C=C stretching in 
aromatic rings1-3 changed to a broad peak at 1532 cm–1 in the spectrum of the GM. In 
the region of 2750–3000 cm–1, bands of OFC attributed to the C-H stretching in the CH3 
group and CH2 group37 were observed for the PM but were not clearly observed for the 
 37 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19. Infrared spectra of the OFC-OXA system in the range of 3300–2600 cm–1 and 
1800–1500 cm–1: (a) OFC, (b) OXA, (c) PM, and (d) GM. 
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GM. Furthermore, the O-H stretching frequency of OXA shifted from 3087 cm–1 to 
3276 cm–1 in the GM, indicating that the intermolecular hydrogen bonds between OXA 
molecules were broken. The results of the IR spectroscopy suggested that some 
interactions occurred between OFC and OXA at the aromatic ring and/or methyl group 
of OFC with O-H group of OXA. 
Solid-state NMR spectroscopy was used to confirm the interaction between 
OFC and OXA. The 13C CP/MAS spectra for the OFC-OXA system are presented in 
Fig. 20. The chemical shifts of the carbon atoms in this system are summarized in Table 
1. The chemical shift assignment of the carbon atoms of OFC and OXA was based on 
ChemDraw Ultra® software (CambridgeSoft Corporation, Japan). The comparison 
between the spectrum of OFC and that of the complex revealed that there was no 
significant change in the chemical shift of the carbons at positions ac and 7 of OFC, as 
shown in Table 1. On the other hand, the peaks of the carbon at position 5 and of the 
met of OFC shifted upfield, while those of the carbons at positions 6, 7a, 7b, 8, 9, 10, 
and 10a of the aromatic rings shifted downfield. The chemical shift of the C1′′ of OXA 
exhibited a downfield shift in the complex. These results suggested that the tricyclic 
aromatic portion and/or methyl group of OFC interacted with the hydroxyl group close 
to C1′′ of OXA.  
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Fig. 20. 13C solid-state NMR spectra of the OFC-OXA system: (a) OFC, (b) OXA, and 
(c) OFC-OXA complex. Peak assignments are shown in Table 1. 
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Table 1 Chemical shifts (ppm) observed in 13C CP/MAS NMR spectra of OFC, OXA, 
and OFC-OXA complex. 
 
 
 
 
 
 
Position of carbon Ofloxacin 
(ppm) 
Oxalic acid  
(ppm) 
Complex 
(ppm) 
7 175.4  175. 7 
ac 166.2  166.5 
1′′  160.8 162.0 
5 157.9  154.9 
9  144.5  146.3 
10a 133.3  139.2 
7b 125.0  130.7 
10 122.2  125.4 
7a 107.1  118.5 
8, 6  104.2  106.4 
2 68.7  68.2 
2′, 3′, 5′, 6′,3 55.8  55.6 
met′ 47.5  47.7 
met 20.1  16.7 
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  Hydrogen bonding is an important intermolecular interaction mode, which is 
responsible for different crystal packing38. IR and NMR results did not confirm the 
presence of hydrogen bonding among the functional groups of OFC and OXA. Hence, 
according to the definition of cocrystal mentioned in Part 1, I classified OFC-OXA 
compound as a complex. Complex is defined as a compound that two or more 
components are held together through weak interactions such as van der Waals force 
and π-stacking, regardless of hydrogen bonding. The OFC-OXA complex appeared to 
be formed by weak interactions such as van der Waals force and OH-pi interaction, 
instead of hydrogen bonding. It has been reported that the OH-pi interaction is involved 
in the formation of the trehalose-benzene complex and trehalose-unsaturated fatty acid 
complex8, 9. 
Terahertz radiation has been used to investigate intermolecular interactions, 
and THz spectroscopy is one of the alternative methods for characterizing solid 
materials15, 23. Transmission THz-TDS was used as an evaluation method for complex 
formation. Figure 21 depicts the THz spectra of the OFC-OXA system. OFC had a 
characteristic peak at 1.07 THz, while the THz spectrum of OXA was featureless. The 
complex exhibited a distinctive absorption peak at 0.59 THz as compared to those of the 
starting materials. The change observed in the THz spectrum of the complex reflected 
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Fig. 21. Terahertz spectra of OFC-OXA system – (●) OFC, (■) OXA, (▲) OFC-OXA 
complex. 
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the weak interaction in the OFC-OXA complex. From this result, it is worth noting that 
THz spectroscopy can probe weak interactions, comparing to FT-IR spectroscopy. The 
difference in the THz spectra between the complex and the starting components 
indicated that OFC interacted with OXA. As reported by Nguyen et al. (2007), 
THz-TDS has been used to monitor the cocrystal formation induced by cogrinding 
phenazine and mesaconic acid. Even though the assignment of THz peak is still difficult 
in this experiment owing to the lack of crystallographic data and the subsequent 
vibrational mode calculation, a distinguished spectral difference suggested complex 
formation induced by cogrinding. In recent years, computational simulation of 
vibrational spectra to obtain molecular level information has become increasingly 
common8.  
In addition to OFC-OXA complex, the complex formation of OFC with other 
dicarboxylic acids such as MLE, GLU, and MLO was investigated. The PXRD patterns 
of OFC-dicarboxylic acid system are shown in Fig. 22. Similar to the OFC-OXA system, 
GMs at a molar ratio of 1:2 (OFC: dicarboxylic acid) showed new PXRD patterns, 
suggesting that a complex was formed between OFC and dicarboxylic acid. The THz 
spectra of other OFC-dicarboxylic acid complexes were also investigated (Fig. 23). The 
THz spectrum of the OFC-MLE complex was featureless, while the OFC-GLU complex  
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Fig. 22. Powder X-ray diffraction patterns of OFC-dicarboxylic acids systems: a) MLE, 
b) OFC:MLE 1:2 PM, c) OFC:MLE 1:2 GM, d) GLU, e) OFC:GLU 1:2 PM,  
f) OFC:GLU 1:2 GM, g) MLO, h) OFC:MLO 1:2 PM, i) OFC:MLO 1:2 GM  
(○ OFC, △ MLE, ◇ GLU, ● MLO, ☆ new peak). 
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Fig. 23. Terahertz spectra of the OFC-dicarboxylic acid system: (a) MLE, (b) GLU, and 
(c) MLO systems. 
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exhibited new peaks at 0.98 and 1.27 THz. The OFC-MLO complex had a new peak at 
1.17 THz. All these complexes showed distinct spectra (i.e., new peak appearance or 
peak disappearance) from those of their starting materials, reflecting the difference in 
molecular packing.  
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CONCLUSIONS 
Seven cocrystals were prepared and characterized by THz spectroscopy. It was 
found that THz spectra of cocrystals were different from those of their starting materials. 
The spectral patterns were changed by the cocrystal formation. Therefore, THz 
spectroscopy was appeared to be a convenient analytical method to detect the cocrystal 
formation.  
When OFC and OXA were coground at molar ratio of 1:2, the complex was 
formed. This complexation did not involved hydrogen bond formation between OFC 
and OXA. Weak interaction such as van der Waals force and/or OH-πinteraction 
occurred, as indicated by the IR and NMR spectra. The THz spectral patterns of OFC, 
OXA, and complex were different in the observed frequency range. The distinctive THz 
spectrum of complex showed that the vibration modes were different from those of 
starting materials, reflecting the weak interaction in the complex. Though the 
assignment of THz peaks is still difficult now, further progress of computational 
calculation will make it possible to do vibrational mode calculation for the peak 
assignment. Terahertz spectroscopy can provide a convenient and rapid method for the 
evaluation of the complex formation especially for the complexes which hydrogen 
bonding is not clearly observed by FT-IR spectroscopy. 
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